New Strategy for Myelin Repair Targeted by Society-Funded Team
May 10, 2021
Researchers at the University of Buffalo have identified “SULF2,” a molecule involved in cell signaling, as a possible target for strategies to promote the repair of myelin, the substance that surrounds nerve fibers and is damaged in MS. SULF2 is found at high levels in brain lesions in people with MS; when SULF2 is deleted from MS mouse models, myelin repair is accelerated.
The team also reports that PI-88, a SULF2-blocker now in clinical trials to treat cancer, improves repair in mice with damaged myelin. This research was supported in part by the National MS Society, and the team leveraged these results to gain funding from the Department of Defense’s MS Research Program to continue exploring whether PI-88 has potential as a myelin repair treatment to restore function in MS.
Read more from the University at Buffalo
Read the scientific publications on this research in Nature Communications
and The Journal of Neuroscience
The National MS Society, founded in 1946, funds cutting-edge research, drives change through advocacy, and provides programs and services to help people affected by MS live their best lives. Connect to learn more and get involved: nationalMSsociety.org, Facebook, Twitter, Instagram, YouTube or 800-344-4867.